Arkstone Support

OneChoice® is a patent-pending technology that selects the most appropriate treatment regimen for a particular patient given the organisms present, resistan...

The OneChoice Report is classified as a clinical decision-making tool under FDA guidelines. This means that while our recommendations can help providers mak...

OneChoice recommendations are based on published and accepted medical data. This includes Infectious Disease Society of America (IDSA) and the CDC guideline...

Arkstone analyzes the source of the sample and differentiates between organisms more likely to be pathogenic and the cause of infection, as opposed to the o...

No. Arkstone only analyzes data sent by the lab which includes organisms and resistance genes detected, patient demographics, diagnosis codes, and patient a...

OneChoice® provides dosing for antibiotics based on some patient-specific criteria giving prescribers a baseline point of reference. However, dosing may not...

Arkstone provides the minimal duration of treatment required to treat simple infections, however, prescribers should adjust accordingly based on the clinica...

Arkstone does not make any diagnosis determinations. Treatment recommendations base the diagnosis on the ICD10 code the provider enters on the laborator...

No. Arkstone does not take into account basic lab work or labs and medical information outside of what the lab sends.

Arkstone will still provide a OneChoice Report, however, the recommendation will only take into account the information that was sent by the lab. Infor...